Unicycive Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Unicycive Therapeutics, Inc. (UNCY) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents26.149.700.4616.580.00
Cash & Short-Term Investments26.149.700.4616.580.00
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.940.332.031.710.00
Total Current Assets30.9513.402.6418.410.20
Non-Current Assets
Property, Plant & Equipment (Net)0.720.790.170.330.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.720.790.170.330.00
Total Assets31.6714.192.8218.740.20
Current Liabilities
Accounts Payable0.970.820.890.740.18
Short-Term Debt0.090.020.050.030.00
Accrued Liabilities3.563.232.241.210.18
Other Current Liabilities18.9413.130.000.000.00
Total Current Liabilities24.1217.533.282.112.88
Non-Current Liabilities
Long-Term Debt0.120.470.000.160.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.120.470.000.160.00
Total Liabilities24.2418.003.282.262.88
Stockholders' Equity
Common Stock0.110.040.020.020.01
Retained Earnings-101.27-64.54-34.00-15.94-5.92
Additional Paid-in Capital108.5960.7033.5232.410.00
Shares Outstanding11.383.481.521.500.00
Total Stockholders' Equity7.43-3.81-0.4716.48-2.67
Total Liabilities & Equity31.6714.192.8218.740.00